Is Solesence, Inc. Common Stock (SLSN) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Solesence, Inc. Common Stock (SLSN) using a discounted cash flow (DCF) model and long-term earnings assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SLSN a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SLSN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

SLSN

Solesence, Inc. Common Stock

$0.86

0.05

(6.11%)

Exchange:
Market Cap:	60.669M
Shares Outstanding:	45.021M

Overview

Earnings

Financials

Valuation

Chart

About The Company

Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.

Click to read more…